FY2025 EPS Estimates for Albemarle Co. (NYSE:ALB) Raised by Analyst

Albemarle Co. (NYSE:ALB) – Investment analysts at Scotiabank lifted their FY2025 earnings per share (EPS) estimates for Albemarle in a research note issued on Monday, May 6th. Scotiabank analyst B. Isaacson now forecasts that the specialty chemicals company will post earnings per share of $9.48 for the year, up from their prior forecast of $9.30. Scotiabank has a “Sector Outperform” rating and a $150.00 price target on the stock. The consensus estimate for Albemarle’s current full-year earnings is $2.86 per share.

Albemarle (NYSE:ALB) last posted its quarterly earnings data on Thursday, May 2nd. The specialty chemicals company reported $0.26 earnings per share for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.09). The firm had revenue of $1.36 billion during the quarter, compared to analysts’ expectations of $1.29 billion. Albemarle had a return on equity of 14.53% and a net margin of 4.02%. The business’s revenue for the quarter was down 47.3% compared to the same quarter last year. During the same period last year, the company earned $10.32 earnings per share.

A number of other brokerages also recently commented on ALB. TD Cowen downgraded shares of Albemarle from an “outperform” rating to a “market perform” rating and dropped their target price for the stock from $220.00 to $130.00 in a research note on Monday, January 29th. Loop Capital reduced their price target on shares of Albemarle from $168.00 to $162.00 and set a “buy” rating for the company in a report on Friday, March 15th. Citigroup boosted their price objective on shares of Albemarle from $125.00 to $135.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 10th. Mizuho lifted their price target on Albemarle from $112.00 to $128.00 and gave the company a “neutral” rating in a report on Thursday, May 2nd. Finally, Bank of America upgraded Albemarle from a “neutral” rating to a “buy” rating and lifted their target price for the company from $137.00 to $156.00 in a research note on Wednesday, April 10th. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Albemarle has an average rating of “Hold” and an average price target of $172.05.

Albemarle Price Performance

ALB opened at $130.40 on Wednesday. Albemarle has a 52-week low of $106.69 and a 52-week high of $247.44. The stock has a market cap of $15.33 billion, a P/E ratio of 47.42, a PEG ratio of 2.80 and a beta of 1.65. The business has a fifty day moving average of $123.47 and a 200 day moving average of $125.93. The company has a quick ratio of 1.91, a current ratio of 2.84 and a debt-to-equity ratio of 0.37.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Raymond James & Associates raised its stake in Albemarle by 2.9% in the 3rd quarter. Raymond James & Associates now owns 110,918 shares of the specialty chemicals company’s stock valued at $18,860,000 after purchasing an additional 3,113 shares during the last quarter. Raymond James Financial Services Advisors Inc. lifted its stake in shares of Albemarle by 16.7% in the third quarter. Raymond James Financial Services Advisors Inc. now owns 74,045 shares of the specialty chemicals company’s stock worth $12,591,000 after buying an additional 10,623 shares in the last quarter. Stratos Wealth Partners LTD. boosted its position in Albemarle by 49.7% during the third quarter. Stratos Wealth Partners LTD. now owns 3,463 shares of the specialty chemicals company’s stock worth $589,000 after acquiring an additional 1,149 shares during the last quarter. Brown Advisory Inc. grew its stake in Albemarle by 14.8% during the 3rd quarter. Brown Advisory Inc. now owns 10,277 shares of the specialty chemicals company’s stock valued at $1,748,000 after acquiring an additional 1,324 shares in the last quarter. Finally, Forsta AP Fonden lifted its stake in Albemarle by 0.9% in the 3rd quarter. Forsta AP Fonden now owns 22,600 shares of the specialty chemicals company’s stock worth $3,843,000 after purchasing an additional 200 shares in the last quarter. 92.87% of the stock is owned by institutional investors and hedge funds.

Albemarle Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, July 1st. Investors of record on Friday, June 14th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.23%. The ex-dividend date of this dividend is Friday, June 14th. Albemarle’s dividend payout ratio (DPR) is presently 58.18%.

Albemarle Company Profile

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.